BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 20823130)

  • 81. A novel role for survivin in erythroblast enucleation.
    Keerthivasan G; Liu H; Gump JM; Dowdy SF; Wickrema A; Crispino JD
    Haematologica; 2012 Oct; 97(10):1471-9. PubMed ID: 22491741
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Histone deacetylase inhibitors induce apoptosis in peripheral blood lymphocytes along with histone H4 acetylation and the expression of the linker histone variant, H1 degrees.
    Sourlingas TG; Tsapali DS; Kaldis AD; Sekeri-Pataryas E
    Eur J Cell Biol; 2001 Nov; 80(11):726-32. PubMed ID: 11824792
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Nuclear levels and patterns of histone H3 modification and HP1 proteins after inhibition of histone deacetylases.
    Bártová E; Pacherník J; Harnicarová A; Kovarík A; Kovaríková M; Hofmanová J; Skalníková M; Kozubek M; Kozubek S
    J Cell Sci; 2005 Nov; 118(Pt 21):5035-46. PubMed ID: 16254244
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Differential modulation of the oligodendrocyte transcriptome by sonic hedgehog and bone morphogenetic protein 4 via opposing effects on histone acetylation.
    Wu M; Hernandez M; Shen S; Sabo JK; Kelkar D; Wang J; O'Leary R; Phillips GR; Cate HS; Casaccia P
    J Neurosci; 2012 May; 32(19):6651-64. PubMed ID: 22573687
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Gene induction and repression during terminal erythropoiesis are mediated by distinct epigenetic changes.
    Wong P; Hattangadi SM; Cheng AW; Frampton GM; Young RA; Lodish HF
    Blood; 2011 Oct; 118(16):e128-38. PubMed ID: 21860024
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Induction of gamma-globin by histone deacetylase inhibitors.
    McCaffrey PG; Newsome DA; Fibach E; Yoshida M; Su MS
    Blood; 1997 Sep; 90(5):2075-83. PubMed ID: 9292546
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Treatment of nuclear-donor cells or cloned zygotes with chromatin-modifying agents increases histone acetylation but does not improve full-term development of cloned cattle.
    Sangalli JR; De Bem TH; Perecin F; Chiaratti MR; Oliveira Lde J; de Araújo RR; Valim Pimentel JR; Smith LC; Meirelles FV
    Cell Reprogram; 2012 Jun; 14(3):235-47. PubMed ID: 22468998
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Effect of valproic acid in comparison with vorinostat on cell growth inhibition and apoptosis induction in the human colon cancer SW48 cells in vitro.
    Sanaei M; Kavoosi F; Mansoori O
    Exp Oncol; 2018 Jun; 40(2):95-100. PubMed ID: 29949538
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Histone deacetylase modulates the proinflammatory and -fibrotic changes in tubulointerstitial injury.
    Marumo T; Hishikawa K; Yoshikawa M; Hirahashi J; Kawachi S; Fujita T
    Am J Physiol Renal Physiol; 2010 Jan; 298(1):F133-41. PubMed ID: 19906951
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The regulatory role of histone deacetylase inhibitors in Fgf4 expression is dependent on the differentiation state of pluripotent stem cells.
    Shi G; Gao F; Jin Y
    J Cell Physiol; 2011 Dec; 226(12):3190-6. PubMed ID: 21321941
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy.
    Kong Y; Tannous P; Lu G; Berenji K; Rothermel BA; Olson EN; Hill JA
    Circulation; 2006 Jun; 113(22):2579-88. PubMed ID: 16735673
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Comparison between the effects of valproic acid and trichostatin A on the in vitro development, blastocyst quality, and full-term development of mouse somatic cell nuclear transfer embryos.
    Costa-Borges N; Santaló J; Ibáñez E
    Cell Reprogram; 2010 Aug; 12(4):437-46. PubMed ID: 20698782
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Identification of two new synthetic histone deacetylase inhibitors that modulate globin gene expression in erythroid cells from healthy donors and patients with thalassemia.
    Mai A; Jelicic K; Rotili D; Di Noia A; Alfani E; Valente S; Altucci L; Nebbioso A; Massa S; Galanello R; Brosch G; Migliaccio AR; Migliaccio G
    Mol Pharmacol; 2007 Nov; 72(5):1111-23. PubMed ID: 17666592
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The role of histone acetylation in SMN gene expression.
    Kernochan LE; Russo ML; Woodling NS; Huynh TN; Avila AM; Fischbeck KH; Sumner CJ
    Hum Mol Genet; 2005 May; 14(9):1171-82. PubMed ID: 15772088
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Histone deacetylase 1 and 2 drive differentiation and fusion of progenitor cells in human placental trophoblasts.
    Jaju Bhattad G; Jeyarajah MJ; McGill MG; Dumeaux V; Okae H; Arima T; Lajoie P; Bérubé NG; Renaud SJ
    Cell Death Dis; 2020 May; 11(5):311. PubMed ID: 32366868
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Regulation of RNA polymerase II activity is essential for terminal erythroid maturation.
    Murphy ZC; Murphy K; Myers J; Getman M; Couch T; Schulz VP; Lezon-Geyda K; Palumbo C; Yan H; Mohandas N; Gallagher PG; Steiner LA
    Blood; 2021 Nov; 138(18):1740-1756. PubMed ID: 34075391
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Analyses of erythropoiesis from embryonic stem cell-CD34
    Wang S; Zhao H; Zhang H; Gao C; Guo X; Chen L; Lobo C; Yazdanbakhsh K; Zhang S; An X
    J Cell Mol Med; 2022 Apr; 26(8):2404-2416. PubMed ID: 35249258
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Iron dose-dependent differentiation and enucleation of human erythroblasts in serum-free medium.
    Byrnes C; Lee YT; Meier ER; Rabel A; Sacks DB; Miller JL
    J Tissue Eng Regen Med; 2016 Feb; 10(2):E84-9. PubMed ID: 23606586
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Analysis of primitive erythroid cell proliferation and enucleation using a cyan fluorescent reporter in transgenic mice.
    Vacaru AM; Isern J; Fraser ST; Baron MH
    Genesis; 2013 Nov; 51(11):751-62. PubMed ID: 23913596
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Systematic Epigenomic Analysis Reveals Chromatin States Associated with Melanoma Progression.
    Fiziev P; Akdemir KC; Miller JP; Keung EZ; Samant NS; Sharma S; Natale CA; Terranova CJ; Maitituoheti M; Amin SB; Martinez-Ledesma E; Dhamdhere M; Axelrad JB; Shah A; Cheng CS; Mahadeshwar H; Seth S; Barton MC; Protopopov A; Tsai KY; Davies MA; Garcia BA; Amit I; Chin L; Ernst J; Rai K
    Cell Rep; 2017 Apr; 19(4):875-889. PubMed ID: 28445736
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.